Advertisement

Acute Myocardial Infarction

Chapter
  • 262 Downloads
Part of the Treatment in Clinical Medicine book series (TC MEDICINE)

Abstract

Acute myocardial infarction develops when myocardial ischaemia occurs for a sufficient time to cause necrosis of a localised area of myocardium. The initial reduction in myocardial blood flow may be secondary to:
  1. 1.

    Coronary artery spasm or increased vasoconstrictor tone in normal or severely stenosed coronary arteries (Maseri et al. 1978)

     
  2. 2.

    Platelet aggregation in the presence of severe atheroma, leading to reduced flow

     
  3. 3.

    Subintimal haemorrhage with bleeding into an atheromatous plaque

     
  4. 4.

    Intracoronary thrombosis (Davies et al. 1976)

     
Infarction may occur without totoal coronary artery occlusion when coronary flow falls due to severe hypotension. This can be associaed with haemorrhage, trauma, severe dehydration or shock accompanying any other condition.

Keywords

Acute Myocardial Infarction Infarct Size Myocardial Blood Flow Cardiogenic Shock Coronary Artery Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adgey AAJ, Geddes JS, Mulholland HC, Keegan DAJ, Pantridge JF (1968) Incidence, significance, and management of early bradyarrhythmia complicating acute myocardial infarction. Lancet II: 1097–1101CrossRefGoogle Scholar
  2. Alderman EL, Barry WH, Graham AF, Harrison DC (1972) Haemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med 287: 13, 623–625PubMedCrossRefGoogle Scholar
  3. Anderson JL, Marshall HW, Bray BE (1983) A randomised trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 308: 1312–1318PubMedCrossRefGoogle Scholar
  4. Anticoagulants in acute myocardial infarction; results of co-operative clinical trial. (1973) JAMA 225: 724–729Google Scholar
  5. Blanke H, Von Hardenberg D, Cohen M (1984) Patterns of creatine kinase release during acute myocardial infarction after non surgical reperfusion: comparison with conventional treatment and correlation with infarct size. J Am Coll Cardiol 3: 675–680PubMedCrossRefGoogle Scholar
  6. Campbell RWF, Murray A (1980) Significance of arrhythmias in the early and late phase of myocardial infarction. In: Lindgren A, Söner AB (eds) Acute and long-term management of myocardial ischaemia. Hjalmarson and Wilhelmson, Mölndal, Sweden, pp 130–136Google Scholar
  7. Colling A, Dellipiani AW, Donaldson RJ, MacCormack P (1976) Teesside coronary survey: an epidemiological study of acute attacks of myocardial infarction. Br Med J II: 1169–1172CrossRefGoogle Scholar
  8. Davies MJ, Woolf N, Robertson WB (1976) Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J 38: 659-664PubMedCrossRefGoogle Scholar
  9. Dellipiani AW, Colling WA, Donaldson RJ, McCormack P (1977) Teesside coronary survey: fatality and comparative severity of patients treated at home, in the hospital ward and in the coronary care unit after myocardial infarction. Br Heart J 39: 1172–1178PubMedCrossRefGoogle Scholar
  10. De Wood MA, Spores J, Notske R (1980) Prevalence of total coronary occlusion during the early hours of trasmural myocardial infarction. N Engl J Med 303: 897–902CrossRefGoogle Scholar
  11. Ganz W, Geft I, Maddahi J, Berman D, Charuzi Y, Shah PK, Swan HJ (1983) Nonsurgical reperfusion in evolving myocardial infarction. J Am Coll Cardiol I: 1247–1253CrossRefGoogle Scholar
  12. Genton MD, Turpie AGG (1983) Anticoagulant therapy following acute myocardial infarction. Part II antithrombotic therapy. Mod Cone Cardiovasc Dis 52: 10: 49–51Google Scholar
  13. Goldman L, Feinstein AR (1979) Anticoagulants and myocardial infarction. Ann Intern Med 90: 92–94PubMedGoogle Scholar
  14. Han J, Moe GK (1964) Nonuniform recovery of excitability in ventricular muscle. Circ Res 14: 44PubMedGoogle Scholar
  15. Hill JD, Hampton JR, Mitchell JRA (1978) A randomised trial of home versus hospital management for patients with suspected myocardial infarction. Lancet I: 837CrossRefGoogle Scholar
  16. Hugenholtz PG, Rentrop P (1982) Thrombolytic therapy for acute myocardial infarction quo vadis? A review of the recent literature. Eur Heart J 2: 395–403Google Scholar
  17. Jewitt DE, Maurer BJ, Hubner PJB (1970) Increased pulmonary arterial pressures after pentazocine in myocardial infarction. Br Med J I: 795–796CrossRefGoogle Scholar
  18. Kennedy JW, Ritchie JL, Davis KB, Fritz JK (1983) Western Washington Randomised Trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 309: 1477–1482PubMedCrossRefGoogle Scholar
  19. Kotter V, Von Leatner ER, Wunderlich J, Schroder R (1977) Comparison of effects of phentolamine, sodium nitroprusside and glyceryl trinitrate in acute myocardial infarction. Br Heart J 39:1196-1204PubMedCrossRefGoogle Scholar
  20. Leir CV, Heban PT, Huss P, Bush CA, Lewis RP (1978) Comparative systemic and regional haemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58: 466–475Google Scholar
  21. Loeb HS, Pietras RJ, Tobin JR, Gunnar RM (1968) Hypovolaemia in shock due to acute myocardial infarction. Circulation 40: 653–659Google Scholar
  22. Loeb HS, Bredakis J, Gunnar R (1977) Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55: 375–381PubMedGoogle Scholar
  23. Lown B, Fakhro AM, Hood WB Jr, Thorn GW (1967) The coronary care unit: new perspectives and directions. JAMA 199: 188PubMedCrossRefGoogle Scholar
  24. MacDonald HR, Rees HA, Muir AL, Lawrie DM, Burton JL, Donald KW (1967) Circulatory effects of heroin in patients with acute myocardial infarction. Lancet I: 1070–1074CrossRefGoogle Scholar
  25. Maling HM, Moran NC (1957) Ventricular arrhythmias induced by sympathomimetic amines in unanaesthetized dogs following coronary artery occlusion. Circ Res 5: 409PubMedGoogle Scholar
  26. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J, Braunwald E (1971) Factors influencing infarct size following experimental coronary artery occlusion. Circulation 43: 67PubMedGoogle Scholar
  27. Maroko PR, Radvany P, Braunwald E, Hale SL (1975) Reduction of infarct size of oxygen inhalation following acute coronary occlusion. Circulation 52: 360PubMedGoogle Scholar
  28. Maroko PR, Hillis LD, Muller JE, Braunwald E (1977) Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med 296: 898PubMedCrossRefGoogle Scholar
  29. Maseri A, L’Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi A, Distante A, Pesola A (1978) Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of “preinfarction” angina. N Engl J Med 299: 1271PubMedCrossRefGoogle Scholar
  30. Mather HG, Morgan DC, Pearson NG, Read KLO, Shaw DB, Steed GR, Thome MG, Lawrence CJ, Riley IS (1976) Myocardial infarction: a comparison between home and hospital care for patients. Br Med J I: 925CrossRefGoogle Scholar
  31. Mok MS, Lippmann M, Steen SN (1981) Multidose/observational, comparative clinical analgetic evaluation of buprenorphine. J Clin Pharmacol 21: 323–329PubMedGoogle Scholar
  32. Page DL, Caulfield JB, Kastor JA, Sanders CA (1971) Myocardial changes associated with cardiogenic shock. N Engl J Med 285: 133PubMedCrossRefGoogle Scholar
  33. Pantridge JF, Adgey AAJ (1969) Pre-hospital coronary care. The mobile coronary care unit. Am J Cardiol 24: 666PubMedCrossRefGoogle Scholar
  34. Rentrop KP, Blanke H, Karsch KR, Kreuzer H (1979) Initial experience with transluminal recanalisation of the recently occluded infarct-related coronary artery in acute myocardial infarction: comparison with conventionally treated patients. Clin Cardiol 2: 92–105PubMedGoogle Scholar
  35. Report of the Working Party on Anticoagulant Therapy in Coronary Thrombosis to the Medical Research Council (1969) Assessment of short-term anticoagulant administration after cardiac infarction. Br Med J I: 335–342Google Scholar
  36. Resnekov L (1977) Intermediate coronary care units. JAMA 237: 1697PubMedCrossRefGoogle Scholar
  37. Reynolds AK, Randall LI (1957) Morphine and allied drugs. University of Toronto Press, TorontoGoogle Scholar
  38. Roberts WC, Buja LM (1972) The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction. Am J Med 52: 425PubMedCrossRefGoogle Scholar
  39. Rude RE, Muller JE, Braunwald E (1981) Efforts to limit the size of myocardial infarcts. Ann Intern Med 95: 736–761PubMedGoogle Scholar
  40. Schroeder R, Biamino G, Enz-Rudiger VL (1983) Intravenous short term infusion of streptokinase in acute myocardial infarction. Circulation 67: 536–548CrossRefGoogle Scholar
  41. Scott ME, Orr R (1969) Effects of diamorphine, methadone, morphine and pentazocine in patients with suspected acute myocardial infarction. Lancet I: 1065–1067CrossRefGoogle Scholar
  42. Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens J (1982) Effects of intravenous streptokinase on acute myocardial infarction. N Engl J Med 307: 19 1180–1182PubMedCrossRefGoogle Scholar
  43. Steen SN, Smith RL, Jeretin S (1979) Effect of i.v. buprenorphine in the human respiratory centre. I.R.C.S. Med Sci 7: 597–598Google Scholar
  44. Swan HJC, Ganz W, Forrester J, Marcus H, Diamond G, Chonetti D (1970) Catheterisation of the heart in man with the use of a flow-directed balloon-tipped catheter. N Engl J Med 283: 447–451PubMedCrossRefGoogle Scholar
  45. Thomas M, Malcrona R, Fillmore S, Shillingford J (1965) Haemodynamic effects of morphine in patients with acute myocardial infarction. Br Heart J 27: 863–875PubMedCrossRefGoogle Scholar
  46. Valori C, Thomas M, Shillingford J (1969) Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol 20: 605–617CrossRefGoogle Scholar
  47. Zelis R, Mansour EJ, Capone RJ, Mason DT (1974) The cardiovascular effects of morphine. J Clin Invest 54: 1247–1258PubMedCrossRefGoogle Scholar
  48. Zola EM, McLeod DC (1983) Comparative effects and analgesic efficacy of the agonist-antagonist opioids. Drug Intell Clin Pharm 17: 411–417PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  1. 1.Royal InfirmaryGlasgowScotland, UK
  2. 2.Stobhill General HospitalGlasgowScotland, UK

Personalised recommendations